Ka Yin Kwong
AstraZeneca (Japan)(JP)AstraZeneca (Poland)(PL)AstraZeneca (Finland)(FI)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Virus-based gene therapy research, Chronic Lymphocytic Leukemia Research, RNA Interference and Gene Delivery, HER2/EGFR in Cancer Research
Most-Cited Works
- → Nuclear localization of EGF receptor and its potential new role as a transcription factor(2001)1,062 cited
- → β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression(2000)770 cited
- → Molecular Staging for Survival Prediction of Colorectal Cancer Patients(2005)350 cited
- → Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia(2008)241 cited
- → Multi-Platform, Multi-Site, Microarray-Based Human Tumor Classification(2004)227 cited
- → The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis(2000)160 cited